The US DOT/FMCSA Drug & Alcohol Clearinghouse (Clearinghouse) May 2020 summary report is out. Registration for the Clearinghouse began for all user roles on September 28, 2019, and user roles include: drivers, employers, consortia/third-party administrators (C/TPAs), medical review officers (MROs), and substance abuse professionals (SAPs). Listed in the Clearinghouse are 114,947 employers, 35,532 owner-operators, 60,834 linked to FMCSA portal account, 7,246 C/TPAs, 2,139 SAPs, and 1,440 MROs. Employers are required to conduct queries in the Clearinghouse when hiring a new Commercial Driver’s License (CDL) holder and annually for all CDL drivers they currently employ. To date, there has been a grand total of 905,307 queries conducted through May 2020. Employers or their designated C/TPAs and MROs are required to report violations of the drug and alcohol program.
The violations reported to the Clearinghouse are listed below (more than one substance can appear in a positive drug test):
Marijuana Metabolite (Δ9-THCA) – 10,388
Cocaine Metabolize (BZE) – 3,192
Methamphetamine – 2,184
Amphetamine – 2,108
DILUTE – 945
OXYM – 556
OXYC – 452
HYC – 418
HYM – 363
Morphine – 171
Codeine – 149
6-Acetylmorphine – 113
PCP – 47
Not Identified – 39
MDMA – 20
MDA – 11
If a driver has a drug and alcohol program violation recorded against him or her in the Clearinghouse, that driver must be removed from safety-sensitive functions, including operating a commercial motor vehicle, until he or she has completed a return-to-duty (RTD) process. Select milestones of a driver’s RTD process are also recorded in the Clearinghouse.
Enroll in the NRCME Training Institute today or purchase our $99 NRCME Exam Reference Materials. Call us at (941) 600-8411 for more program information and for any current single provider enrollment discounts.